(19)
(11) EP 4 135 710 A1

(12)

(43) Date of publication:
22.02.2023 Bulletin 2023/08

(21) Application number: 20872608.3

(22) Date of filing: 23.09.2020
(51) International Patent Classification (IPC): 
A61K 31/58(2006.01)
C07J 3/00(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07J 43/003; A61P 25/00
(86) International application number:
PCT/US2020/052167
(87) International publication number:
WO 2021/067089 (08.04.2021 Gazette 2021/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.09.2019 US 201962907763 P

(71) Applicant: Eliem Therapeutics (UK) Ltd
Altrincham, Cheshire, WA14 2DT (GB)

(72) Inventors:
  • LEVIN, Andrew, D.
    Newton, MA 02458 (US)
  • BUCKLEY, Neil
    Raleigh, NC 27607 (US)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) COMPOSITIONS THAT PREFERENTIALLY POTENTIATE SUBTYPES OF GABAA RECEPTORS AND METHODS OF USE THEREOF